The functional significance behind expressing two IL-8 receptor types on PMN

ELR-CXC Chemokine Receptor Antagonism Targets Inflammatory Responses at Multiple Levels

(2009) X. Zhao et al.   JOURNAL OF IMMUNOLOGY

Therapeutic Effect of Blocking CXCR2 on Neutrophil Recruitment and Dextran Sodium Sulfate-Induced Colitis

(2009) S. M. Farooq et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Amelioration of Pathology by ELR-CXC Chemokine Antagonism in a Swine Model of Airway Endotoxin Exposure

(2009) John R. Gordon et al.   Journal of Agromedicine

The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature

(2008) Fernanda M. Coelho et al.   ARTHRITIS AND RHEUMATISM

CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2–DOP receptor heterodimer

(2008) Geraldine Parenty et al.   BIOCHEMICAL JOURNAL

Therapeutic inhibition of CXCR2 by Reparixin attenuates acute lung injury in mice

(2008) A Zarbock et al.   BRITISH JOURNAL OF PHARMACOLOGY

Emerging Pharmacotherapies for COPD

(2008) Peter J. Barnes   CHEST

The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice

(2008) Allisson Freire Bento et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Effects of epithelial and neutrophil CXCR2 on innate immunity and resistance to kidney infection

(2008) M. Svensson et al.   KIDNEY INTERNATIONAL

CXCR2 antagonists for the treatment of pulmonary disease

(2008) R.W. Chapman et al.   PHARMACOLOGY & THERAPEUTICS

Interleukin-8 induction by the environmental contaminant benzo(a)pyrene is aryl hydrocarbon receptor-dependent and leads to lung inflammation

(2008) Normand Podechard et al.   TOXICOLOGY LETTERS

Intracellular cross-talk between the GPCR CXCR1 and CXCR2: Role of carboxyl terminus phosphorylation sites

(2007) Hila Attal et al.   EXPERIMENTAL CELL RESEARCH